| View |
|
DRP-8581-03
|
Docetaxel
|
Doxagen 20
|
40mg/mL (20mg/0.5mL)
|
Concentrate Solution for IV Infusion
|
Antineoplastic
|
Venus Remedies, Limited
|
India
|
CLIDP Conversion
|
30 June 2023
|
18 December 2024
|
| View |
|
DRP-8580-03
|
Docetaxel
|
Doxagen 80
|
|
40mg/mL (80mg/2mL)
|
Antineoplastic
|
Venus Remedies, Limited
|
India
|
CLIDP Conversion
|
03 July 2023
|
18 December 2024
|
| View |
|
DRP-8582-02
|
Paclitaxel
|
Taxegen 30
|
6mg/mL (30mg/5mL)
|
Concentrate Solution for Infusion (IV)
|
Antineoplasitc
|
Venus Remedies, Limited
|
India
|
CLIDP Conversion
|
15 June 2023
|
18 December 2024
|
| View |
|
DRP-8583-02
|
Paclitaxel
|
Taxegen 100
|
6 mg / mL (100 mg / 16.7 mL)
|
Concentrate Solution for Infusion (IV)
|
Antineoplasitc
|
Venus Remedies, Limited
|
India
|
CLIDP Conversion
|
03 July 2023
|
18 December 2024
|
| View |
|
DRP-10530-03
|
Linezolid
|
Lizod
|
2 mg/mL (600 mg/300 mL)
|
Solution for Injection for I.V. Infusion
|
Antibacterial (Oxazolidinone)
|
Ahlcon Parenterals (India) Limited
|
India
|
CLIDP Conversion
|
25 May 2023
|
12 October 2026
|
| View |
|
DRP-10530-04
|
Linezolid
|
Loxenil IV
|
2mg/mL (600mg/300mL)
|
Solution for I.V. Infusion
|
Antibacterial (Oxazolidinone)
|
Ahlcon Parenterals (India) Limited
|
India
|
CLIDP Conversion
|
03 July 2023
|
12 October 2026
|
| View |
|
DRP-10892-03
|
Zoledronic Acid (As Monohydrate)
|
Zondrax
|
800 mcg/mL (4 mg/5 mL)
|
Concentrated Solution for Injection (IV Infusion)
|
Bisphosphonate
|
Aroma Ilac San. Ltd. Sti
|
Turkey
|
CLIDP Conversion
|
22 March 2023
|
14 December 2026
|
| View |
|
DRP-12881-01
|
Sitagliptin (as phophate) + Metformin Hydrochloride
|
Co-Zincretin 50/500
|
50 mg/ 500 mg
|
Film-Coated Tablet
|
Antidiabetic Agent (Dipeptidyl Peptidase 4 (DPP-4) Inhibitor/Biguanide)
|
Eskayef Pharmaceuticals Limited
|
Bangladesh
|
CLIDP Conversion
|
09 August 2023
|
24 October 2027
|
| View |
|
DRP-12736-08
|
Telmisartan + Amlodipine (as besilate)
|
Zamplify 40/10
|
40 mg/10 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
11 June 2024
|
30 September 2027
|
| View |
|
DRP-12736-1
|
Telmisartan + Amlodipine (as besilate)
|
Telmicass Plus
|
40 mg / 10 mg
|
Tablet
|
Angiotensin II Receptor Blocker / Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
23 August 2023
|
30 September 2027
|
| View |
|
DR-XY49102
|
Tadalafil
|
Torfil 5
|
5 mg
|
Film-Coated Tablet
|
Drug Used in Erectile Dysfunction
|
Torrent Pharmaceuticals Ltd.
|
India
|
Initial
|
03 June 2024
|
03 June 2029
|
| View |
|
DR-XY49103
|
Telmisartan + Hydrochlorothiazide
|
Telarb Plus
|
80 mg/ 25 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB) + Diuretic,
|
Inventia Healthcare Limited.
|
India
|
Initial
|
03 June 2024
|
03 June 2029
|
| View |
|
DR-XY49104
|
Telmisartan + Hydrochlorothiazide
|
Telarb Plus
|
40 mg/ 12.5 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB) + Diuretic
|
Inventia Healthcare Limited
|
India
|
Initial
|
03 June 2024
|
03 June 2029
|
| View |
|
DR-XY49105
|
Telmisartan + Hydrochlorothiazide
|
Telarb Plus
|
80 mg/ 12.5 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB) + Diuretic
|
Inventia Healthcare Limited
|
India
|
Initial
|
03 June 2024
|
03 June 2029
|
| View |
|
DRHR-2363
|
Isopropyl Alcohol + Chlorhexidine Gluconate (Vet.)
|
Zeptadone
|
70 mL (70% v/v)/2 g (2% w/v) per 100 mL
|
Solution
|
Antiseptic/Disinfectant
|
Greatstar Laboratories.
|
Philippines
|
Initial
|
04 June 2024
|
04 June 2029
|
| View |
|
DRHR-2284
|
Isopropyl Alcohol
|
Pro-Defense
|
70 mL (70% v/v) per 100 mL
|
Topical Solution (with
Moisturizer)
|
Antiseptic/Disinfectant
|
Medipak Manufacturing Inc.
|
Philippines
|
Initial
|
05 June 2024
|
05 June 2026
|
| View |
|
DRP-15279
|
Ascorbic Acid
|
Access Cee
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate)
|
Capsule
|
Vitamin
|
Opal Laboratories (Pvt.) Limited.
|
Pakistan
|
Initial [OTC]
|
05 June 2024
|
05 June 2029
|
| View |
|
DRP-15283
|
Paracetamol
|
Parmol
|
120 mg/5 mL
|
Oral Suspension (Mango Flavor)
|
Analgesic/Antipyretic
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
Initial [OTC]
|
05 June 2024
|
05 June 2029
|
| View |
|
DRP-15271
|
Tenofovir Disoproxil Fumarate
|
Tenoliv
|
300 mg
|
Film-Coated Tablets
|
Antiviral (Nucleoside and nucleotide reverse
transcriptase inhibitor)
|
RV Lifesciences Limited
|
India
|
Initial
|
04 June 2024
|
04 June 2029
|
| View |
|
DRP-15263
|
Vildagliptin
|
None
|
50 mg
|
Tablet
|
Blood glucose lowering drug (Dipeptidyl peptidase 4
(DPP-4) inhibitor)
|
Bafna Pharmaceuticals Limited.
|
India
|
Initial
|
04 June 2024
|
04 June 2026
|